Sentinel node mapping for colorectal cancer with radioactive tracer

Area of Science:

• Oncology
• Surgical Oncology
• Nuclear Medicine

Background:

• Colorectal cancer staging relies on accurate assessment of regional lymph node metastasis.
• Sentinel lymph node biopsy (SLNB) is a minimally invasive technique to identify the first lymph nodes draining a primary tumor.
• Radioactivity-guided SLNB offers a precise method for sentinel node identification.

Purpose of the Study:

• To evaluate the feasibility and accuracy of radioactivity-guided sentinel lymph node mapping in colorectal cancer.
• To determine the diagnostic performance of sentinel node biopsy for detecting metastasis.

Main Methods:

• 56 patients with resectable colorectal cancer underwent preoperative endoscopic injection of technetium Tc 99m-labeled tin colloid.
• Intraoperative identification of radioactive sentinel nodes was performed using a gamma probe.
• Standard radical resection and histopathologic examination of all resected nodes were conducted.

Main Results:

• Sentinel nodes were successfully detected in 91% of patients.
• The sentinel node metastasis rate (22%) was significantly higher than in non-sentinel nodes (3%).
• Overall diagnostic accuracy was 92%, with 100% accuracy for T1/T2 tumors.

Conclusions:

• Radioactivity-guided sentinel node mapping is accurate and feasible for staging T1/T2 colorectal cancer.
• SLNB can be a sensitive and specific method for detecting lymph node metastasis in colorectal cancer.
• This technique may improve the precision of regional lymph node assessment in colorectal cancer management.